Every one of those 1 sits in a single category, market-trends. Of the tracked stories, 1 of 1 also mention Aged Garlic Extract, the most common co-covered peer. We currently track 1 Healthcare story that mention Allicin, all published on February 19, 2026.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about Allicin
Every one of those 1 sits in a single category, market-trends. Of the tracked stories, 1 of 1 also mention Aged Garlic Extract, the most common co-covered peer. We currently track 1 Healthcare story that mention Allicin, all published on February 19, 2026. Each carries 5 original sources on average.
Stories tracked
1
Sources per story
5
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 16 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering Allicin. Shared-story counts are live from our verified record — not editorial picks.
A widespread consumer health push is highlighting garlic supplements as a dual-action tool for cardiovascular maintenance and immune system resilience. As clinical evidence mounts for allicin-derived compounds, the supplement market is shifting toward standardized, high-potency formulations to meet aging population demands.